Lipotoxicity plays a key role in the development of both insulin resistance and muscle atrophy in patients with type 2 diabetes
Open accessThe DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Abstract
Summary: Insulin resistance and muscle mass loss often coincide in individuals with type 2 diabetes. Most patients with type 2 diabetes are overweight, and it is well established that obesity and derangements in lipid metabolism play an important role in the development of insulin resistance in these individuals. Specifically, increased adipose tissue mass and dysfunctional adipose tissue lead to systemic lipid overflow and to low‐grade inflammation via altered secretion of adipokines and cytokines. Furthermore, an increased flux of fatty acids from the adipose tissue may contribute to increased fat storage in the liver and in skeletal muscle, resulting in an altered secretion of hepatokines, mitochondrial dysfunction, and impaired insulin signalling in skeletal muscle. Recent studies suggest that obesity and lipid derangements in adipose tissue can also lead to the development of muscle atrophy, which would make insulin resistance and muscle atrophy two sides of the same coin. Unfortunately, the exact relationship between lipid accumulation, type 2 diabetes, and muscle atrophy remains largely unexplored. The aim of this review is to discuss the relationship between type 2 diabetes and muscle loss and to discuss some of the joint pathways through which lipid accumulation in organs may affect peripheral insulin sensitivity and muscle mass.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197 · cited 1×
“Kelley et al observed mitochondrial abnormalities with respect to content, size, and morphology in patients with T2D,(113) while Mootha et al showed a lower gene expression of peroxisome proliferator‐activated receptor gamma coactivator 1‐alpha (PGC1α), a key transcriptional cofactor in mitochondrial biogenesis, and a…”
BackgroundObesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
Cho, N. H., Shaw, J. E., Karuranga, S., Huang, Y., da Rocha Fernandes, J. D., Ohlrogge, A. W., & Malanda, B. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.02.023 · Cited by 7,283 · cited 1×
“The number of adults with diabetes in the world increased from 108 million in 1980 to 422 million in 2014,(1) and by 2045, this number is expected to increase to 693 million.(2) Type 2 diabetes (T2D) is the most common form of this disease and accounts for 85% to 95% of the cases.”
BackgroundXu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760 · cited 1×
“Macrophages are also believed to be an important contributor of insulin resistance.(56,57)”
BackgroundLeptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Fielding, R. A., Vellas, B., Evans, W. J., Bhasin, S., Morley, J. E., Newman, A. B., Abellan van Kan, G., Andrieu, S., Bauer, J., Breuille, D., et al. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.01.003 · Cited by 3,256
Goodpaster, B. H., Park, S. W., Harris, T. B., Kritchevsky, S. B., Nevitt, M., Schwartz, A. V., Simonsick, E. M., Tylavsky, F. A., Visser, M., Newman, A. B., et al. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.10.1059 · Cited by 3,083 · cited 1×
“In fact, changes in lean mass can only explain a small part (5%) of the variability in strength decline, underscoring the importance of muscle quality and the central neural and neuromuscular components determining muscle strength and function.(169,170) Apart from exercise and nutrition, also, pharmacological interven…”
Background
Cited by
The burden and risks of emerging complications of diabetes mellitus
Tomic, D., Shaw, J. E., & Magliano, D. J. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00690-7 · Cited by 1,163
Exercise and metabolic health: beyond skeletal muscle
Thyfault, J. P., & Bergouignan, A. (2020) · Diabetologia · doi:10.1007/s00125-020-05177-6 · Cited by 410
Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities
Opazo-Ríos, L., Mas, S., Marín-Royo, G., Mezzano, S., Gómez-Guerrero, C., Moreno, J. A., & Egido, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072632 · Cited by 363
Inter-organ crosstalk during development and progression of type 2 diabetes mellitus
Xourafa, G., Korbmacher, M., & Roden, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00898-1 · Cited by 274
“Lipid oxidation and impairment of diacylglycerol–nPKC signalling combined with impaired mitochondrial oxidation largely explain myocellular insulin resistance 4,22 and reduced functionality, termed sarcopenia 117 .”
BackgroundInsulin Signal Transduction Perturbations in Insulin Resistance
Khalid, M., Alkaabi, J., Khan, M. A. B., & Adem, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168590 · Cited by 233
“The correlation between lipotoxicity and insulin resistance is well established and involves multiple pathways [16].”
BackgroundTermannsen, A., Clemmensen, K. K. B., Thomsen, J. M., Nørgaard, O., Díaz, L. J., Torekov, S. S., Quist, J. S., & Færch, K. (2022) · Obesity Reviews · doi:10.1111/obr.13462 · Cited by 78
The impact of vegan diet in the prevention and treatment of type 2 diabetes: A systematic review
Pollakova, D., Andreadi, A., Pacifici, F., Della-Morte, D., Lauro, D., & Tubili, C. (2021) · Nutrients · doi:10.3390/nu13062123 · Cited by 67
“Excessive IMCL storage has a cytotoxic effect on mitochondria through reactive oxygen species (ROS) overproduction and increased metabolic stress which promotes the insulin resistance [28].”
BackgroundInflammation and metabolism: the role of adiposity in sarcopenic obesity
Lynch, G. M., Murphy, C. H., Castro, E. D. M., & Roche, H. M. (2020) · Proceedings of the Nutrition Society · doi:10.1017/s0029665120007119 · Cited by 41
“Thus together IR and AR may act synergistically to develop a state of metabolic frailty, that can culminate in a triad of T2D, sarcopenia and sarcopenic obesity((49)).”
BackgroundYu, F., Fan, Y., Sun, H., Li, T., Dong, Y., & Pan, S. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109881 · Cited by 28
Effect of Ketogenic Diet on Obesity and Other Metabolic Disorders: Narrative Review
Baylie, T., Ayelgn, T., Tiruneh, M., & Tesfa, K. (2024) · Diabetes, Metabolic Syndrome and Obesity · doi:10.2147/dmso.s447659 · Cited by 27
“Higher metabolic efficiency in consuming fats that is indicated by the reduction in the resting respiratory quotient; 44,45 and (4) Enhanced energy consumption as a result of increased gluconeogenesis, a high-energy process that costs 400–600 Kcal/day, and the thermic action of protein, which has…”
BackgroundCao, X., & Thyfault, J. P. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112178 · Cited by 25
Metadata
- Authors
- Meex, R. C. R., Blaak, E. E., & van Loon, L. J. C.
- Venue
- Obesity Reviews
- Publisher
- Wiley
- Published
- 2019-06-26
- Volume
- 20
- Issue
- 9
- Pages
- 1205-1217
- ISSN
- 1467-7881 (ISSN-L)
- 1467-789X
- OpenAlex
- W2954341057
- Cited by
- 211
- References
- 85
- FWCI
- 14.90
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.